Study: Hydroxychloroquine Still Problematic Drug

A large study on the use of hydroxychloroquine to treat COVID-19 patients is finding patients receiving the drug were more likely to die or develop dangerous heart arrhythmias.  President Trump has promoted the use of the anti-malaria drug and says he’s taking it himself.  Medical journal The Lancet reported today the study looked at data from 96-thousand patients from nearly 700 hospitals.  About 15-thousand were treated with the anti-malaria drugs and an antibiotic.  All four of the different treatments tried were linked to a higher risk of dying.  About one in eleven in the study did die.